Table 6.
The influence factor for the improvement of the left ventricular systolic function in ESRD patients post-PTX on multiple logistic regression analysis (n = 35)
| OR(95%CI) | P value | |
|---|---|---|
| Post-PTX | ||
| ACEI | – | – |
| ARBs | 0.397 (0.027, 5.898) | 0.502 |
| calcium blockers | 0.506 (0.020, 12.694) | 0.679 |
| cardiotonics | – | – |
| β-blockers | 10.505 (0.728, 151.527) | 0.084 |
| isosorbide mononitrate | 0.062 (0.000, 7.811) | 0.259 |
| trimetazidine | 0.781 (0.064, 4.813) | 0.996 |
| systolic pressure mmHg | 0.958 (0.887,1.034) | 0.272 |
| diastolic pressure mmHg | 1.125 (0.965, 1.312) | 0.133 |
The influence factors for the improvement of the left ventricular systolic function in ESRD patients 1-year post-PTX were analyed using multiple logistic regression analysis, unadjusted
ACEI angiotensin-converting enzyme inhibitors, ARBs angiotensin receptor blockers